ArticleCancer science2016

Metformin inhibits estrogen-dependent endometrial cancer cell growth by activating the AMPK-FOXO1 signal pathway.

Jingfang Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.